Osimertinib for Patients With Leptomeningeal Metastases Associated With EGFR T790M-Positive Advanced NSCLC: The AURA Leptomeningeal Metastases Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Osimertinib for Patients With Leptomeningeal Metastases Associated With EGFR T790M-Positive Advanced NSCLC: The AURA Leptomeningeal Metastases Analysis

Published:2020-04 Issue:4 Volume:15 Page:637-648
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Ahn Myung-Ju,Chiu Chao-Hua,Cheng Ying,Han Ji-Youn,Goldberg Sarah B.,Greystoke Alastair,Crawford Jeffrey,Zhao Yanqiu,Huang Xiangning,Johnson Martin,Vishwanathan Karthick,Yates James W.T.,Brown Andrew P.,Mendoza-Naranjo Ariadna,Mok Tony

Funder

Roche

Pfizer

Ono Pharmaceutical

Genentech

Helsinn

Eli Lilly and Company

Merck

Merck Sharp & Dohme

Novartis

Bristol-Myers Squibb

Clovis Oncology

AstraZeneca

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference41 articles.

1. Therapy of leptomeningeal metastasis in solid tumors;Mack;Cancer Treat Rev,2016

2. Carcinomatous meningitis: leptomeningeal metastases in solid tumors;Le Rhun;Surg Neurol Int,2013

3. Leptomeningeal metastases in patients with NSCLC with EGFR mutations;Li;J Thorac Oncol,2016

4. Epidermal growth factor receptor tyrosine kinase inhibitors for non-small-cell lung cancer patients with leptomeningeal carcinomatosis;Liao;J Thorac Oncol,2015

5. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors;Lee;J Thorac Oncol,2013

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape;Cancer Treatment Reviews;2024-11

2. Treatment Advances in Lung Cancer with Leptomeningeal Metastasis;Current Cancer Drug Targets;2024-09

3. Exposure–response modelling of osimertinib in patients with non‐small cell lung cancer;British Journal of Clinical Pharmacology;2024-08-19

4. Lazertinib in EGFR-Variant Non–Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors;JAMA Oncology;2024-08-15

5. Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation–Positive Non–Small Cell Lung Cancer (BLOSSOM);Journal of Clinical Oncology;2024-08-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3